Support Material for the EURORDIS Summer School The Orphan Drug Development Taskforce had been working with more than 20 experts from the field of Rare Diseases for 2 years to help reach IRDiRC goals, namely the goal 2 ‘1000 new therapies for rare diseases will be approved, the majority of which will focus on diseases … Continue reading IRDiRC’s Orphan Drug Development Guidebook